| Date | Form | Description | Docs | XBRL | Pages |
| 12/22/03 | 10-K | Annual report pursuant to section 13 and 15(d) |
|
51 | |
| 02/13/03 | 10-K | Annual report pursuant to section 13 and 15(d) |
|
49 | |
| 01/29/03 | NT 10-K | Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10KT |
|
3 | |
| 01/29/02 | 10-K | Annual report pursuant to section 13 and 15(d) |
|
48 | |
| 02/01/01 | 10-K/A | Annual report pursuant to section 13 and 15(d) |
|
35 | |
| 01/29/01 | 10-K | Annual report pursuant to section 13 and 15(d) |
|
35 | |
| 01/28/00 | 10-K | Annual report pursuant to section 13 and 15(d) |
|
60 | |
| 03/31/99 | 10-K/A | Annual report pursuant to section 13 and 15(d) |
|
13 | |
| 01/29/99 | 10-K405 | Annual report [Sections 13 and 15(d), S-K Item 405] |
|
42 | |
| 01/29/98 | 10-K405 | Annual report [Sections 13 and 15(d), S-K Item 405] |
|
40 |
Latest News & Events
Anixa Biosciences Announces VA North Texas Health Care System to Join Cchek™ Prostate Cancer Study
Read More...Anixa Biosciences Announces Additional Patent Issued on Cancer Detection Technology
Read More...Anixa Biosciences Announces U.S. Department of Veterans Affairs VA Maryland Health Care System Joins Cchek™ Prostate Cancer Study
Read More...Cancer of the Lung, Breast, Colon, Prostate, and Stomach are the five most prevalent cancers worldwide.